Patient Investing in Step Change Innovation
By Charles Breese, Managing Director of Larpent Newton and Co Ltd. The timing of being invited to write this article is perfect, coinciding as it does with a) the huge
By Charles Breese, Managing Director of Larpent Newton and Co Ltd. The timing of being invited to write this article is perfect, coinciding as it does with a) the huge
► The falling oil price has had many consequences, both politically and economically. In this article we look at the financial effects and, in particular at the shale oil industry.
Advanced Oncotherapy Plc (LON:AVO) Focused on delivering a more affordable, novel proton-based radiotherapy system, based on a technology originally developed and tested at the world renowned CERN facility in Switzerland.
R.E.A. Holdings Plc (LON:RE) 2015 has been a tough year with harsh climatic conditions and depressed commodity prices. We are forecasting a small and reduced profit for the year as
Premaitha Health Plc (LON:NIPT) uses the latest advances in DNA sequencing technology for non-invasive prenatal screening tests. IONA estimates the risk that a fetus has any of Down’s, Edwards’ or
PPHE Hotel Group Ltd (LON:PPH), the asset-backed, London-focused hotel operator, has announced its Q4 trading update, which confirms the strong trends at the interim results and Q3 update. We revised
Tissue Regenix Group Plc (LON:TRX) is no longer an R&D play. Its dCELL® technology enables production of ‘like-for-like’ tissue specific, structure-preserving scaffolds that have been validated in multiple clinical settings.
Redx Pharma Plc (LON:REDX) is a drug discovery company, offering investors access to a new R&D model; not without risk, but one that is mitigated by the breadth, depth and
The Fantastic Four is Marvel’s original and longest running superhero team who,through a cosmic incident, develop super powers; and then use them for good. Reed Richards (Q1) is able to
City of London Investment Group (LON:CLIG) issued a trading update this morning with its figures to the end of 2015. Funds under management were $3.8 billion. This compares with $4.2bn